Molecular Profile
What Is Cagrilintide?
- Type
- Long-acting acylated amylin analog
- Amino acids
- 37 (modified amylin sequence)
- Molecular weight
- 4,409 g/mol
- CAS Number
- 1415456-99-3
- Molecular formula
- C₁₉₄H₃₁₂N₅₄O₅₉S₂
- Modification
- C18 fatty diacid acylation
FOR RESEARCH USE ONLY. This compound is not FDA approved. All data presented is from clinical trials for educational reference.
8x tested · ISO 1702599%+ purityResearch use only
Metabolic Research Peptide
Cagrilintide
NN9838CAS: 1415456-99-3ZP8396
A 37-amino acid long-acting acylated amylin analog that activates amylin and calcitonin receptors to modulate appetite signaling in homeostatic and hedonic brain regions, studied in clinical trials for weight management. Premium Research Peptide.
Mass
Quantity
1
$69.99$45.49
$69.99$45.49
1
Order by 3pm ET to ship same dayCutoff 3:00 PM ET (12:00 PM PT)
Arrives Tue, Aug 25 - Fri, Aug 28Free standard shipping on orders over $100
Free shipment protectionLost, stolen, or damaged? We replace it, on us.
Overnight and 2-day optionsPick your speed at checkout
We acceptSecure 256-bit checkout
Cagrilintide$69.99$45.49
Verified Test Results
Every batch, independently verified.
Each batch is analyzed by an ISO/IEC 17025 accredited third-party laboratory before it ships. This is the released report for the current batch, exactly as the lab signed it.
ILSILS LaboratoriesIndependent, ISO/IEC 17025 accredited
Certificate of Analysis
99.84%
Purity by HPLC
- Lot
- CAG0002
- Tested
- Jul 30, 2026
- Labeled
Technical specifications
Compound Information
Storage Requirements
Stability Information
Store frozen or refrigeratedAvoid repeated freeze-thawProtect from light
Lyophilized (powder)
Store at -20°C long-term
Reconstituted
Recommended condition
Light protection
Protect from light
Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2-8°C applies to reconstituted solutions.
Peer-reviewed literature
The research behind this compound, cited in full.
Every research claim on this page traces back to one of the 10 publications below.
- 01New England Journal of Medicine · 2025Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
- 02The Lancet · 2021Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
-01KYMQP96GMJFNS2XA6FK1WVJG.png&w=3840&q=75&dpl=dpl_52PyoSV4nMPQ4vG8EDjzRHsuEUGN)
-01KYMPT8WGCB2M4VSE0F0NGMY9.png&w=3840&q=75&dpl=dpl_52PyoSV4nMPQ4vG8EDjzRHsuEUGN)
-01KWCZ4XZMAQQGZEYBXD5TF8AA.png&w=3840&q=75&dpl=dpl_52PyoSV4nMPQ4vG8EDjzRHsuEUGN)
